Cargando…
Frequent MED12 mutations in phyllodes tumours of the breast
BACKGROUND: Phyllodes tumours are rare fibroepithelial tumours of the breast, that include benign, borderline, and malignant lesions. Although the molecular basis of phyllodes tumours largely remains unknown, a recent exome study identified MED12 mutations as a sole recurrent genetic alteration in f...
Autores principales: | Yoshida, M, Sekine, S, Ogawa, R, Yoshida, H, Maeshima, A, Kanai, Y, Kinoshita, T, Ochiai, A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4430713/ https://www.ncbi.nlm.nih.gov/pubmed/25839987 http://dx.doi.org/10.1038/bjc.2015.116 |
Ejemplares similares
-
TERT promoter mutations are frequent and show association with MED12 mutations in phyllodes tumors of the breast
por: Yoshida, Masayuki, et al.
Publicado: (2015) -
Droplet-digital PCR reveals frequent mutations in TERT promoter region in breast fibroadenomas and phyllodes tumours, irrespective of the presence of MED12 mutations
por: Otsuji, Kazutaka, et al.
Publicado: (2020) -
MED12 exon 2 mutations in phyllodes tumors of the breast
por: Nagasawa, Satoi, et al.
Publicado: (2015) -
MED12, TERT promoter and RBM15 mutations in primary and
recurrent phyllodes tumours
por: Garcia-Dios, Diego A, et al.
Publicado: (2018) -
MED12 mutations in breast phyllodes tumors: evidence of temporal tumoral heterogeneity and identification of associated critical signaling pathways
por: Laé, Marick, et al.
Publicado: (2016)